Capital Investment Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $353K | Buy |
4,416
+15
| +0.3% | +$1.2K | 0.03% | 415 |
|
2025
Q1 | $381K | Sell |
4,401
-11
| -0.2% | -$953 | 0.03% | 371 |
|
2024
Q4 | $365K | Buy |
4,412
+10
| +0.2% | +$826 | 0.04% | 358 |
|
2024
Q3 | $383K | Buy |
4,402
+10
| +0.2% | +$870 | 0.04% | 347 |
|
2024
Q2 | $361K | Sell |
4,392
-925
| -17% | -$76K | 0.04% | 354 |
|
2024
Q1 | $426K | Buy |
5,317
+9
| +0.2% | +$721 | 0.05% | 333 |
|
2023
Q4 | $404K | Sell |
5,308
-1,763
| -25% | -$134K | 0.04% | 336 |
|
2023
Q3 | $512K | Sell |
7,071
-430
| -6% | -$31.1K | 0.05% | 266 |
|
2023
Q2 | $567K | Buy |
7,501
+15
| +0.2% | +$1.13K | 0.06% | 255 |
|
2023
Q1 | $569K | Buy |
7,486
+19
| +0.3% | +$1.44K | 0.07% | 241 |
|
2022
Q4 | $587K | Buy |
7,467
+7,038
| +1,641% | +$553K | 0.07% | 237 |
|
2022
Q3 | $31K | Buy |
429
+1
| +0.2% | +$72 | ﹤0.01% | 611 |
|
2022
Q2 | $32K | Hold |
428
| – | – | ﹤0.01% | 634 |
|
2022
Q1 | $34K | Sell |
428
-49
| -10% | -$3.89K | ﹤0.01% | 663 |
|
2021
Q4 | $39K | Buy |
477
+1
| +0.2% | +$82 | ﹤0.01% | 627 |
|
2021
Q3 | $37K | Hold |
476
| – | – | ﹤0.01% | 587 |
|
2021
Q2 | $38K | Sell |
476
-51
| -10% | -$4.07K | ﹤0.01% | 606 |
|
2021
Q1 | $42K | Sell |
527
-150
| -22% | -$12K | 0.01% | 555 |
|
2020
Q4 | $48K | Buy |
677
+1
| +0.1% | +$71 | 0.01% | 524 |
|
2020
Q3 | $43K | Hold |
676
| – | – | 0.01% | 459 |
|
2020
Q2 | $44K | Buy |
676
+526
| +351% | +$34.2K | 0.01% | 414 |
|
2020
Q1 | $8K | Buy |
150
+50
| +50% | +$2.67K | ﹤0.01% | 483 |
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 500 |
|
2019
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 1099 |
|
2019
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 1100 |
|
2019
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 906 |
|
2018
Q4 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 908 |
|